Cardiovascular complications of novel Wuhan Coronavirus (COVID-19) – A 2020 update
Rajesh Rajan, Mohammed Al‐Jarallah, Raja Dashti
Abstract
load induced cardiac injury was seen in 7.2% of admitted patients. Arrythmias were seen in 16.7%. Known coronary artery disease and heart failure patients are at a higher risk when compared to others. We can expect cardiac arrest due toacute myocarditis, acute myocardial infarction, and rapid-onset heart failure. 3 In previous outbreaks of SARS/MERS patients with HFrEF had higher requirement of ventilators. 4 As of now there is no anti-viral treatment proven to be effective for Novel Wuhan Coronavirus COVID-19. Lopinavir and Ritonavir is widely using as per its previous data on SARS and MERS. Use of steroids is controversial as it has no proven benefits on mortality.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusVirologyCoronavirus InfectionsPandemicCardiologyInternal medicineDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19